These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

387 related articles for article (PubMed ID: 34381710)

  • 21. m6A modification in RNA: biogenesis, functions and roles in gliomas.
    Zhang Y; Geng X; Li Q; Xu J; Tan Y; Xiao M; Song J; Liu F; Fang C; Wang H
    J Exp Clin Cancer Res; 2020 Sep; 39(1):192. PubMed ID: 32943100
    [TBL] [Abstract][Full Text] [Related]  

  • 22. N6-methyladenine modification in noncoding RNAs and its function in cancer.
    Yang X; Hu X; Liu J; Wang R; Zhang C; Han F; Chen Y; Ma D
    Biomark Res; 2020 Nov; 8(1):61. PubMed ID: 33292652
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Reduced m6A modification predicts malignant phenotypes and augmented Wnt/PI3K-Akt signaling in gastric cancer.
    Zhang C; Zhang M; Ge S; Huang W; Lin X; Gao J; Gong J; Shen L
    Cancer Med; 2019 Aug; 8(10):4766-4781. PubMed ID: 31243897
    [TBL] [Abstract][Full Text] [Related]  

  • 24. RNA m6A methylation regulators in endometrial cancer (Review).
    Shen S; Guo J; Lv N; Chen Q; Tong J
    Int J Oncol; 2022 Dec; 61(6):. PubMed ID: 36321774
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Emerging function of N6-methyladenosine in cancer.
    Hong K
    Oncol Lett; 2018 Nov; 16(5):5519-5524. PubMed ID: 30344705
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The Impact of m6A RNA Modification in Therapy Resistance of Cancer: Implication in Chemotherapy, Radiotherapy, and Immunotherapy.
    Shriwas O; Mohapatra P; Mohanty S; Dash R
    Front Oncol; 2020; 10():612337. PubMed ID: 33718113
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Expression Pattern and Prognostic Value of Key Regulators for m6A RNA Modification in Hepatocellular Carcinoma.
    Zhang L; Qiao Y; Huang J; Wan D; Zhou L; Lin S; Zheng S
    Front Med (Lausanne); 2020; 7():556. PubMed ID: 33072775
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Expression and Prognostic Characteristics of m6A RNA Methylation Regulators in Colon Cancer.
    Huang L; Zhu J; Kong W; Li P; Zhu S
    Int J Mol Sci; 2021 Feb; 22(4):. PubMed ID: 33670062
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Emerging role of m6A methylation modification in ovarian cancer.
    Chang LL; Xu XQ; Liu XL; Guo QQ; Fan YN; He BX; Zhang WZ
    Cancer Cell Int; 2021 Dec; 21(1):663. PubMed ID: 34895230
    [TBL] [Abstract][Full Text] [Related]  

  • 30. M6A RNA methylation in biliary tract cancer: the function roles and potential therapeutic implications.
    Bai X; Huang J; Jin Y; Chen J; Zhou S; Dong L; Han X; He X
    Cell Death Discov; 2024 Feb; 10(1):83. PubMed ID: 38365891
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The Effect of m6A Methylation Regulatory Factors on the Malignant Progression and Clinical Prognosis of Hepatocellular Carcinoma.
    Zhao Z; Yang L; Fang S; Zheng L; Wu F; Chen W; Song J; Chen M; Ji J
    Front Oncol; 2020; 10():1435. PubMed ID: 32974160
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The Biological Function, Mechanism, and Clinical Significance of m6A RNA Modifications in Head and Neck Carcinoma: A Systematic Review.
    Jing FY; Zhou LM; Ning YJ; Wang XJ; Zhu YM
    Front Cell Dev Biol; 2021; 9():683254. PubMed ID: 34136491
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The emerging role of RNA N6-methyladenosine methylation in breast cancer.
    Zheng F; Du F; Zhao J; Wang X; Si Y; Jin P; Qian H; Xu B; Yuan P
    Biomark Res; 2021 May; 9(1):39. PubMed ID: 34044876
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Link Between m6A Modification and Cancers.
    Liu ZX; Li LM; Sun HL; Liu SM
    Front Bioeng Biotechnol; 2018; 6():89. PubMed ID: 30062093
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Current insights into the implications of m6A RNA methylation and autophagy interaction in human diseases.
    Chen X; Wang J; Tahir M; Zhang F; Ran Y; Liu Z; Wang J
    Cell Biosci; 2021 Jul; 11(1):147. PubMed ID: 34315538
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Functions of N6-methyladenosine and its role in cancer.
    He L; Li H; Wu A; Peng Y; Shu G; Yin G
    Mol Cancer; 2019 Dec; 18(1):176. PubMed ID: 31801551
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Role of DNA and RNA N6-Adenine Methylation in Regulating Stem Cell Fate.
    Wu Y; Zhou C; Yuan Q
    Curr Stem Cell Res Ther; 2018; 13(1):31-38. PubMed ID: 28637404
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The interplay between m6A RNA methylation and noncoding RNA in cancer.
    Ma S; Chen C; Ji X; Liu J; Zhou Q; Wang G; Yuan W; Kan Q; Sun Z
    J Hematol Oncol; 2019 Nov; 12(1):121. PubMed ID: 31757221
    [TBL] [Abstract][Full Text] [Related]  

  • 39. m6A RNA methylation regulators can contribute to malignant progression and impact the prognosis of bladder cancer.
    Chen M; Nie ZY; Wen XH; Gao YH; Cao H; Zhang SF
    Biosci Rep; 2019 Dec; 39(12):. PubMed ID: 31808521
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Changes of N6-methyladenosine modulators promote breast cancer progression.
    Wu L; Wu D; Ning J; Liu W; Zhang D
    BMC Cancer; 2019 Apr; 19(1):326. PubMed ID: 30953473
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 20.